These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27890669)

  • 1. Doxorubicin: nanotechnological overviews from bench to bedside.
    Cagel M; Grotz E; Bernabeu E; Moretton MA; Chiappetta DA
    Drug Discov Today; 2017 Feb; 22(2):270-281. PubMed ID: 27890669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
    Xiong XB; Ma Z; Lai R; Lavasanifar A
    Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years.
    D'Angelo NA; Noronha MA; Câmara MCC; Kurnik IS; Feng C; Araujo VHS; Santos JHPM; Feitosa V; Molino JVD; Rangel-Yagui CO; Chorilli M; Ho EA; Lopes AM
    Biomater Adv; 2022 Feb; 133():112623. PubMed ID: 35525766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGD Peptide-Based Target Drug Delivery of Doxorubicin Nanomedicine.
    Sun Y; Kang C; Liu F; Zhou Y; Luo L; Qiao H
    Drug Dev Res; 2017 Sep; 78(6):283-291. PubMed ID: 28815721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced in vivo toxicity of doxorubicin by encapsulation in cholesterol-containing self-assembled nanoparticles.
    Gonzalez-Fajardo L; Mahajan LH; Ndaya D; Hargrove D; Manautou JE; Liang BT; Chen MH; Kasi RM; Lu X
    Pharmacol Res; 2016 May; 107():93-101. PubMed ID: 26976795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
    Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
    Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc finger-inspired nanohydrogels with glutathione/pH triggered degradation based on coordination substitution for highly efficient delivery of anti-cancer drugs.
    Zhang Z; Wan J; Sun L; Li Y; Guo J; Wang C
    J Control Release; 2016 Mar; 225():96-108. PubMed ID: 26812007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
    Lee BS; Park K; Park S; Kim GC; Kim HJ; Lee S; Kil H; Oh SJ; Chi D; Kim K; Choi K; Kwon IC; Kim SY
    J Control Release; 2010 Oct; 147(2):253-60. PubMed ID: 20624433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of primary and metastatic tumors in mice by E-selectin-targeted polymer-drug conjugates.
    Shamay Y; Raviv L; Golan M; Voronov E; Apte RN; David A
    J Control Release; 2015 Nov; 217():102-12. PubMed ID: 26297207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy.
    Saiyin W; Wang D; Li L; Zhu L; Liu B; Sheng L; Li Y; Zhu B; Mao L; Li G; Zhu X
    Mol Pharm; 2014 May; 11(5):1662-75. PubMed ID: 24666011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles.
    Zhang T; Xiong H; Dahmani FZ; Sun L; Li Y; Yao L; Zhou J; Yao J
    Nanotechnology; 2015 Apr; 26(14):145101. PubMed ID: 25771790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
    Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
    Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextran-coated superparamagnetic nanoparticles as potential cancer drug carriers in vivo.
    Peng M; Li H; Luo Z; Kong J; Wan Y; Zheng L; Zhang Q; Niu H; Vermorken A; Van de Ven W; Chen C; Zhang X; Li F; Guo L; Cui Y
    Nanoscale; 2015 Jul; 7(25):11155-62. PubMed ID: 26062012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
    Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
    Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembled micelles based on Chondroitin sulfate/poly (d,l-lactideco-glycolide) block copolymers for doxorubicin delivery.
    Zhang H; Xu J; Xing L; Ji J; Yu A; Zhai G
    J Colloid Interface Sci; 2017 Apr; 492():101-111. PubMed ID: 28073063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.